The Potential of Antiviral Peptides as COVID-19 Therapeutics
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_72cff7fa5faf43f8ae9f40b2169c6e3c | ||
042 | |a dc | ||
100 | 1 | 0 | |a Arun Suria Karnan Mahendran |e author |
700 | 1 | 0 | |a Yin Sze Lim |e author |
700 | 1 | 0 | |a Chee-Mun Fang |e author |
700 | 1 | 0 | |a Hwei-San Loh |e author |
700 | 1 | 0 | |a Cheng Foh Le |e author |
245 | 0 | 0 | |a The Potential of Antiviral Peptides as COVID-19 Therapeutics |
260 | |b Frontiers Media S.A., |c 2020-09-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2020.575444 | ||
546 | |a EN | ||
690 | |a antiviral peptides | ||
690 | |a antimicrobial peptides | ||
690 | |a antiviral prophylaxis | ||
690 | |a antiviral agents | ||
690 | |a COVID-19 | ||
690 | |a SARS-CoV-2 | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 11 (2020) | |
787 | 0 | |n https://www.frontiersin.org/article/10.3389/fphar.2020.575444/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/72cff7fa5faf43f8ae9f40b2169c6e3c |z Connect to this object online. |